ClinicalTrials.gg
RecruitingNCT05633940Updated Apr 23, 2024

The Effects of Primary Care Behavioral Health in Primary Care in Sweden

An interventional study of Implementation of the service delivery model primary care behavioral health in Primary Health Care, Mental Disorder and Behavioral Symptoms, sponsored by Region Östergötland. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-23.

Sponsored by Region Östergötland · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2021, registered Apr 2021).
  • Started Jan 2021; still recruiting 5 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The novel multi-professional service delivery model "Primary Care Behavioural Health" (PCBH) has been suggested as an effective way to integrate behavioural health services into routine primary care to overcome the growing problems with psychosocial and mental health problems in primary care. In this multicenter mixed-methods pragmatic clinical trial, the implementation of PCBH in routine primary health care in a region in Sweden is investigated.

Read the detailed description

Psychosocial and mental health problems is a growing public health concern and challenge for primary care where resources are scarce. The multi-professional novel service delivery model "Primary Care Behavioural Health" (PCBH) has been suggested as an effective way to integrate behavioural health services into routine primary care. The model offer high accessibility to brief interventions, is clinically intuitively attractive and has been disseminated in primary care organizations globally, as well as in Sweden. However, more research is needed on its effect and implementation in routine care. The objective is to investigate the effect of the new service delivery model PCBH on organization- staff- and patient outcomes, and to investigate the implementation of PCBH in terms of how and to which degree the new way of working is normalised in practice routines. This multicenter mixed-methods interventional study is designed as a controlled pragmatic clinical trial. The effect of PCBH will be investigated on organizational, staff and patient levels. Variables include waiting lists, symptoms, medication prescriptions, quality of life and working environment aspects. Study participants will be patients, staff and managers at the included primary care centers. Implementation of PCBH will be investigated regarding the implementation process and degree of implementation. Data will be both qualitative (individual interviews) and quantitative (registers, biomarkers and questionnaires). At least 24 intervention centers will be compared to an equal number of control centers. The research project will be conducted in several regions in Sweden during a period of 4 years. PCBH seems to offer a solution the challenges in modern primary care, but evidence is low. This study will provide much-needed clinically meaningful data regarding PCBH that hopefully could be used for future development of primary healthcare.

02

Conditions studied

  • Primary Health Care
  • Mental Disorder
  • Behavioral Symptoms
03

In context

Mental Disorders

1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 1,301 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Region Östergötland is the lead sponsor of 29 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patients:

Inclusion Criteria, one of following:

  • Adult patients who seek care for mental health problems at a participating centre,
  • Adult patients who have received any following International Classification of Diseases diagnose: F00-F99, Z56, Z73
  • Adult patients who are prescribed any psychotropic drugs with ATC codes: N05A-C, N06A) at a participating centre.
  • Adult patients who has an appointment to a behavioral health consultant at a participating centre.

Exclusion Criteria:

  • Not capable to leave .

Medical staff:

Inclusion Criteria:

  • Health care professionals employed at a participating centre.

Exclusion Criteria:

  • Temporarily hired personnel, e.g. hired doctors or nurses on weekly basis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Implementation

    The centers that implement PCBH.

    Behavioral: Implementation of the service delivery model primary care behavioral health

  • No intervention
    No implementation

    Control centers that do not implement PCBH.

Interventions

  • BehavioralImplementation of the service delivery model primary care behavioral health

    The research project will study a real-world implementation of PCBH in routine primary care. The implementation is facilitated by a regional implementation group of psychologists with special training in PCBH. The active implementation period for each intervention center is 12 months, where continuous support, materials and training are offered by the implementation group.

06

What researchers measure

Primary outcomes

  1. Accessibility at the health care center, measured in number of visits

    Number of visits to health care professionals treating patients for mental health issues (i.e. behavioral health consultants and physicians).

    Time frame: Baseline to 24 months.

  2. Functional level of the patients.

    Measured by Sheehan disability scale.

    Time frame: Baseline to 24 months.

  3. Work environment among the medical staff

    Measured by the COPSOQ III questionnaire , which is an instrument that measures psychosocial factors, stress, and the well-being of employees.

    Time frame: Baseline to 24 months.

  4. Experience of primary care behavioral health among the medical staff

    Data will be collected through qualitative interviews.

    Time frame: Baseline to 24 months.

Secondary outcomes

  1. Accessibility at the health care center, measured in waiting times.

    Waiting times to first visit to health care professionals treating patients for mental health issues (i.e. behavioral health consultants and physicians).

    Time frame: In total 3 years: one year before baseline (baseline: when implementation starts), thereafter during 2 year from baseline.

  2. Quality of life of the patients.

    Measured by Euroqol 5 dimensions 5 levels, on a scale from 1 to 5 on each item where 1 means no problems and 5 means severe problems.

    Time frame: 2 years from baseline (first visit to a health care professional due to a mental health issue, therafter after 6, 12 and 24 months).

  3. Symptoms of anxiety in the patients.

    Measured by Generalised Anxiety Disorder Assessment (GAD-7), on a scale from 0-21, where higher points means higher risk for anxiety.

    Time frame: 2 years from baseline (first visit to a health care professional due to a mental health issue, therafter after 6, 12 and 24 months).

  4. Symptoms of depression in the patients

    Measured by the patient health questionnaire (PHQ-9) on a scale from 0-27, where higher points means higher risk for depression.

    Time frame: 2 years from baseline (first visit to a health care professional due to a mental health issue, therafter after 6, 12 and 24 months).

  5. Referrals to psychiatric care

    The number of patients with mental health issues who are referred to psychiatric specialist care.

    Time frame: In total 3 years: one year before baseline (baseline: when implementation starts), thereafter during 2 year from baseline.

  6. Work commitment among the medical staff

    Measured by the Utrecht Work Engagement Scale, where higher points mean higher work engagement.

    Time frame: 2 years in total: at baseline, therafter at 6, 12 and 24 months.

  7. Exhaustion among the medical staff

    Measured by the Karolinska exhaustion disorder scale (KEDS), where higher points indicate higher risk for exhaustion disorder.

    Time frame: 2 years in total: at baseline, therafter at 6, 12 and 24 months.

  8. Fidelity to the core components among the medical staff

    Measured by a questionnaire incorporating typical features of work according to primary care behavioral health.

    Time frame: 2 years in total: at baseline, therafter at 6, 12 and 24 months.

  9. Medical treatment of patients due to mental health issues

    Number of patients who are prescribed psychotropic drugs (ATC codes: N05A, N05B, N05C and N06A).

    Time frame: In total 3 years: one year before baseline (baseline: when implementation starts), thereafter during 2 year from baseline.

  10. Sick leave of patients due to mental health issues

    Number of patients who are on sick leave due to mental health issues (defined as sick leave due to one or more F- or Z-diagnoses according to the International Classification of Diseases (ICD-10) codes in the F00-F99, Z56, Z63 and Z73 sections.

    Time frame: In total 3 years: one year before baseline (baseline: when implementation starts), thereafter during 2 year from baseline.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD are not planned to be shared with other researchers.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2021 (actual). Primary completion is estimated for Dec 2026, 71 months after the start.

Of 666 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 71 months is above that.

Counting every sponsor, half of 680 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2021
First posted
Dec 1, 2022
StartActual
Jan 1, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Apr 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05633940
Lead sponsor
Region Östergötland
Collaborators
Region Jönköping County, Region Örebro County
Responsible party
Hanna Israelsson Larsen (Adjunct Senior Lecturer/resident physician in general medicin, Region Östergötland) — Principal investigator
First posted
Dec 1, 2022
Start date
Jan 1, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 23, 2024

Study contacts

Hanna I Larsen, PhD
Contact
hanna.israelsson.larsen@regionostergotland.se
0046101044207
Eva Anskär, Med. Lic.
Contact
Eva.Anskar@regionostergotland.se
0046705654329
Hanna I Larsen, PhD
principal investigator · region östergötland/Primärvårdscentrum/Vårdcentralen Cityhälsan centrum

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion